Short Term Outcomes From Minimally Invasive Surgery for the Treatment of Atrial Fibrillation
The purpose of this study is to assess the efficacy of minimally invasive surgery for atrial fibrillation.
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||Prospective Analysis of the Wolf Minimaze Procedure for Treatment of Atrial Fibrillation|
- Transtelephonic monitoring for the identification of post surgical Atrial Fibrillation [ Time Frame: six months and 1 year ] [ Designated as safety issue: No ]
|Study Start Date:||March 2007|
|Study Completion Date:||May 2012|
|Primary Completion Date:||May 2012 (Final data collection date for primary outcome measure)|
Patients who are undergoing or who have undergone minimally invasive surgery for atrial fibrillation will be followed prospectively. At 6 to 9 months, 1 and two years post surgery follow-up subjects will receive a trans-telephonic monitor to wear for approximately 1 month, and will submit transmissions on a daily basis. Episodes of atrial fibrillation will be documented during this time. The overall efficacy of the procedure will be assessed based on the freedom from atrial fibrillation at the time of transtelephonic monitoring.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00571597
|United States, Virginia|
|Division of Cardiology Virginia Commonwealth University|
|Richmond, Virginia, United States, 23298|
|Principal Investigator:||Kenneth A Ellenbogen, MD||Virginia Commonwealth University|